JP2023071670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023071670A5 JP2023071670A5 JP2023016485A JP2023016485A JP2023071670A5 JP 2023071670 A5 JP2023071670 A5 JP 2023071670A5 JP 2023016485 A JP2023016485 A JP 2023016485A JP 2023016485 A JP2023016485 A JP 2023016485A JP 2023071670 A5 JP2023071670 A5 JP 2023071670A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- peptide
- concentration
- pharmaceutically acceptable
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025113059A JP2025163025A (ja) | 2016-11-13 | 2025-07-03 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662421332P | 2016-11-13 | 2016-11-13 | |
| US62/421,332 | 2016-11-13 | ||
| PCT/US2017/061343 WO2018089909A1 (en) | 2016-11-13 | 2017-11-13 | Compositions and methods for treating diabetes, hypertension and hypercholesterolemia |
| JP2019524445A JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524445A Division JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113059A Division JP2025163025A (ja) | 2016-11-13 | 2025-07-03 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023071670A JP2023071670A (ja) | 2023-05-23 |
| JP2023071670A5 true JP2023071670A5 (enExample) | 2023-11-21 |
| JP7711967B2 JP7711967B2 (ja) | 2025-07-23 |
Family
ID=62107069
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524445A Pending JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| JP2023016485A Active JP7711967B2 (ja) | 2016-11-13 | 2023-02-07 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
| JP2025113059A Pending JP2025163025A (ja) | 2016-11-13 | 2025-07-03 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524445A Pending JP2020502056A (ja) | 2016-11-13 | 2017-11-13 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113059A Pending JP2025163025A (ja) | 2016-11-13 | 2025-07-03 | 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10548941B2 (enExample) |
| EP (1) | EP3538124A4 (enExample) |
| JP (3) | JP2020502056A (enExample) |
| KR (1) | KR102497242B1 (enExample) |
| CN (1) | CN110087666B (enExample) |
| AU (2) | AU2017357052B2 (enExample) |
| BR (1) | BR112019009511A2 (enExample) |
| MX (1) | MX2019005466A (enExample) |
| WO (1) | WO2018089909A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3538124A4 (en) * | 2016-11-13 | 2020-07-22 | Imagine Pharma | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA |
| BR112020013845A2 (pt) * | 2018-01-09 | 2020-12-01 | Imagine Pharma, Llc | polipeptídeo ou formulação, métodos para modulação de crescimento celular endotelial e para tratamento de uma doença, e, uso de um polipeptídeo ou formulação. |
| MX2020014242A (es) * | 2018-06-25 | 2021-05-27 | Imagine Pharma Llc | Composiciones y métodos para propagar las células de islotes productoras de insulina y usos terapéuticos de las mismas. |
| CN110974943A (zh) * | 2019-12-09 | 2020-04-10 | 广东药科大学 | 一种口服胰岛素药物制剂及其制备方法 |
| CN116685344A (zh) * | 2020-12-08 | 2023-09-01 | 想象制药有限责任公司 | 治疗伤口的组合物和方法 |
| AU2022349361A1 (en) * | 2021-09-22 | 2024-03-07 | Imagine Pharma Llc | Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof |
| US20250388638A1 (en) * | 2021-12-11 | 2025-12-25 | Imagine Pharma Llc | Compositions and methods for oral delivery |
| WO2025207834A1 (en) * | 2024-03-28 | 2025-10-02 | Imagine Pharma Llc | Dietary supplements, compositions, and uses thereof for increasing telomerase activity and extending telomere length |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4025395B2 (ja) * | 1997-04-09 | 2007-12-19 | 花王株式会社 | 新規ペクチン酸リアーゼ |
| US20020042062A1 (en) * | 1999-09-24 | 2002-04-11 | Mark Stearns | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AUPR311601A0 (en) * | 2001-02-15 | 2001-03-08 | Adp Pharmaceutical Pty Limited | Matrix gene expression in chondrogenesis |
| US20050118151A1 (en) * | 2001-05-29 | 2005-06-02 | Syddansk Universitet | Proteins in diabetes proteome anlysis |
| WO2003068908A2 (en) * | 2001-07-10 | 2003-08-21 | Gene Logic, Inc. | Cardiotoxin molecular toxicology modeling |
| EP2275127B1 (en) * | 2002-04-02 | 2012-09-19 | Ben Gurion University Of The Negev Research And Development Authority | Protein-based streptococcus pneumoniae vaccines |
| EP1656155A2 (en) * | 2003-06-02 | 2006-05-17 | Ohio University | Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| JP2005245202A (ja) * | 2004-03-01 | 2005-09-15 | Japan Science & Technology Agency | ヒトＴＦＩＩＥαの新規な亜鉛結合ドメインの構造的特徴および機能 |
| WO2008127813A1 (en) * | 2007-03-09 | 2008-10-23 | Hiberna Corporation | Hibernation-related genes and proteins, activators and inhibitors thereof and methods of use |
| WO2010129023A2 (en) * | 2009-04-28 | 2010-11-11 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
| WO2012054739A2 (en) * | 2010-10-21 | 2012-04-26 | New York University | Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding |
| CA2817851A1 (en) * | 2010-11-12 | 2012-05-18 | The Johns Hopkins University | Albumin-bound protein/peptide complex as a biomarker for disease |
| ES2569185T3 (es) | 2011-03-01 | 2016-05-09 | Nucana Biomed Limited | Derivados de fosforamidato de 5-fluoro-2'-desoxiuridina para uso en el tratamiento del cáncer |
| SG11201602012RA (en) * | 2013-09-25 | 2016-04-28 | Pronutria Inc | Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof |
| CN106687128B (zh) * | 2014-10-31 | 2022-05-10 | Ngm生物制药有限公司 | 用于治疗代谢病症的组合物和方法 |
| US20190000923A1 (en) * | 2015-12-22 | 2019-01-03 | Novartis Ag | Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| EP3538124A4 (en) | 2016-11-13 | 2020-07-22 | Imagine Pharma | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA |
| BR112020013845A2 (pt) * | 2018-01-09 | 2020-12-01 | Imagine Pharma, Llc | polipeptídeo ou formulação, métodos para modulação de crescimento celular endotelial e para tratamento de uma doença, e, uso de um polipeptídeo ou formulação. |
-
2017
- 2017-11-13 EP EP17868911.3A patent/EP3538124A4/en active Pending
- 2017-11-13 US US15/811,060 patent/US10548941B2/en active Active
- 2017-11-13 JP JP2019524445A patent/JP2020502056A/ja active Pending
- 2017-11-13 AU AU2017357052A patent/AU2017357052B2/en active Active
- 2017-11-13 CN CN201780069543.0A patent/CN110087666B/zh active Active
- 2017-11-13 KR KR1020197015784A patent/KR102497242B1/ko active Active
- 2017-11-13 BR BR112019009511-0A patent/BR112019009511A2/pt active Search and Examination
- 2017-11-13 WO PCT/US2017/061343 patent/WO2018089909A1/en not_active Ceased
- 2017-11-13 MX MX2019005466A patent/MX2019005466A/es unknown
-
2019
- 2019-06-28 US US16/455,878 patent/US10751384B2/en active Active
-
2022
- 2022-05-31 AU AU2022203741A patent/AU2022203741B2/en active Active
-
2023
- 2023-02-07 JP JP2023016485A patent/JP7711967B2/ja active Active
-
2025
- 2025-07-03 JP JP2025113059A patent/JP2025163025A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017057230A5 (enExample) | ||
| RU2009102815A (ru) | Полипептиды из neisseria meningitidis | |
| JP2005537234A5 (enExample) | ||
| JP2019533722A5 (enExample) | ||
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| WO2018067217A3 (en) | COMPOSITIONS COMPRISING SHORT PEPTIDES DERIVED FROM PEDF AND USES THEREOF | |
| JP2025163025A5 (enExample) | ||
| JP2023520323A5 (enExample) | ||
| CN102186496A (zh) | 治疗肾功能紊乱的组合物和方法 | |
| MX2019005466A (es) | Composiciones y metodos para tratar diabetes, hipertension e hipercolesterolemia. | |
| JP2023537921A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| JP2020117504A5 (enExample) | ||
| CN107987128A (zh) | 一种功能多肽及其在制备防治肺纤维化药物中的应用 | |
| JP2022553888A5 (enExample) | ||
| JP2026062640A5 (enExample) | ||
| JP2011503008A5 (enExample) | ||
| MX2025012741A (es) | Composiciones farmaceuticas orales | |
| JP2005513036A5 (enExample) | ||
| AR052062A1 (es) | Composicion y metodo para tratar el asma | |
| PL1778209T3 (pl) | Sposoby i kompozycje do doustnego dostarczania FTS | |
| JP2014512369A5 (enExample) | ||
| JP2023517130A5 (ja) | Ａｚｄ１６５６又はその薬学的に許容される塩を含む、コロナウイルスによって引き起こされた肺炎及び／又は心筋炎の治療用組成物 | |
| JP2023516753A5 (enExample) | ||
| JP2015524460A5 (enExample) |